Literature DB >> 20840513

Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference?

A Godier1, M Durand, D Smadja, T Jeandel, J Emmerich, C M Samama.   

Abstract

BACKGROUND: Hydroxyethyl starches (HES) could differ with regard to the origin, and the influence on the coagulation of the raw material is unknown. This study compared the effects of a new potato-derived HES with a maize-derived HES and two crystalloid solutions.
METHODS: Whole blood from 10 healthy individuals was diluted by 20% and 40% using either non-balanced potato-derived HES 130/0.42/6:1, non-balanced maize-derived HES 130/0.4/9:1, isotonic saline or Ringer's lactate solution. Samples were analysed by thromboelastometry ROTEM(®) : Coagulation was initiated by acid ellagic [intrinsic thromboelastometry (INTEM)] or tissue factor (extrinsic thromboelastometry) with and without cytochalasin to determine the functional component of fibrinogen [cytochalasin-d-modified thromboelastometry (FIBTEM)]. Platelet count and fibrinogen activity were measured.
RESULTS: No effect of raw material was found as no difference was detected among the HES solutions. Whatever the solution, progressive haemodilution impaired haemostasis in a dose-dependant manner: For INTEM, the clot formation time was increased up to 308% and the maximum clot firmness (MCF) was decreased down to 49%. As dilution increased, initiation of coagulation was also impaired. Thromboelastometric alterations were more severe with HES than with crystalloids, especially regarding fibrin polymerization explorations: MCF of FIBTEM was considerably reduced from 12[10-14] to 2[2-3] mm (P<0.05). Fibrinogen activity and platelet count were reduced by dilution in a dose-dependant manner and decreased similarly in all groups.
CONCLUSION: Maize- and potato-derived HES have similar effects on coagulation. Both the starch preparations tested lead to more severe haemostatic defects than crystalloids, and impairment of fibrin polymerization appears to be a leading determinant of this coagulopathy.
© 2010 The Authors. Journal compilation © 2010 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20840513     DOI: 10.1111/j.1399-6576.2010.02306.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  10 in total

Review 1.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

Review 2.  Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.

Authors:  Christiane S Hartog; Dorit Reuter; Wolfgang Loesche; Michael Hofmann; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2011-10-12       Impact factor: 17.440

3.  A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution, but does not affect von Willebrand factor function or thromboelastometric measurements--results of a model of in vitro haemodilution.

Authors:  Juliane Rau; Christoph Rosenthal; Elisabeth Langer; Michael Sander; Erika Schulte; Michael Schuster; Christian von Heymann
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

4.  Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.

Authors:  Nicolai Haase; Jørn Wetterslev; Per Winkel; Anders Perner
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440

5.  Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis.

Authors:  Shariq A Khan; Owoicho Adogwa; Tong J Gan; Ulysses T Null; Terence Verla; Sankalp Gokhale; William D White; Gavin W Britz; Ali R Zomorodi; Michael L James; David L McDonagh
Journal:  Springerplus       Date:  2013-07-15

6.  Acid-base and electrolyte status during normovolemic hemodilution with succinylated gelatin or HES-containing volume replacement solutions in rats.

Authors:  Johanna K Teloh; Katja B Ferenz; Frank Petrat; Christian Mayer; Herbert de Groot
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

7.  Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®).

Authors:  Cristina Solomon; Herbert Schöchl; Marco Ranucci; Ulf Schött; Christoph J Schlimp
Journal:  Scand J Clin Lab Invest       Date:  2015-01-19       Impact factor: 1.713

8.  Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.

Authors:  Dag Winstedt; Nahreen Tynngård; Knut Olanders; Ulf Schött
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-03-22       Impact factor: 2.953

9.  Hydroxyethyl starch in severe sepsis: end of starch era?

Authors:  Carlos A Estrada; Raghavan Murugan
Journal:  Crit Care       Date:  2013-03-13       Impact factor: 9.097

Review 10.  Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography.

Authors:  Cristina Solomon; Marco Ranucci; Gerald Hochleitner; Herbert Schöchl; Christoph J Schlimp
Journal:  Anesth Analg       Date:  2015-10       Impact factor: 6.627

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.